115 related articles for article (PubMed ID: 1382672)
1. The 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine causes a differential incorporation of hexadecanol into neutral ether ester glycerolipids of 2 variant cell lines of rat colon carcinoma.
Mjabri B; Boucrot P; Aubry J
Arch Int Physiol Biochim Biophys; 1992; 100(3):237-40. PubMed ID: 1382672
[TBL] [Abstract][Full Text] [Related]
2. Hexadecanoic and neuraminic acid incorporations in two rat colon carcinoma cell lipids: selective influence of 1-O-octadecyl 2-O-methyl-3-phosphocholine on glycerolipid and ganglioside biosynthesis.
Mjabri B; Boucrot P; Aubry J
Arch Int Physiol Biochim; 1990 Aug; 98(4):163-71. PubMed ID: 1707612
[TBL] [Abstract][Full Text] [Related]
3. Severe modifications of ether- ester- or diester-linked glycerolipid and non glycerolipid synthesis in human neuroblastoma LAN-1 cells cultured with octadecylmethylglycerophosphocholine.
Boucrot P; Aubry J; Mezazigh A
Arch Physiol Biochem; 1995 May; 103(2):165-74. PubMed ID: 9338088
[TBL] [Abstract][Full Text] [Related]
4. Effect of octadecylmethylglycerophosphocholine and hexadecylmethylglycerol on arachidonic acylation or release in macrophages.
Boucrot P; Lelain R; Petit JY; Welin L
J Lipid Mediat Cell Signal; 1994 May; 9(3):247-54. PubMed ID: 7921784
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antineoplastic properties of ether-linked thioglycolipids.
Guivisdalsky PN; Bittman R; Smith Z; Blank ML; Snyder F; Howard S; Salari H
J Med Chem; 1990 Sep; 33(9):2614-21. PubMed ID: 2391700
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes.
Achterberg V; Gercken G
Mol Biochem Parasitol; 1987 Mar; 23(2):117-22. PubMed ID: 3574353
[TBL] [Abstract][Full Text] [Related]
8. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
9. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
[TBL] [Abstract][Full Text] [Related]
10. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Small GW; Strum JC; Daniel LW
Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959
[TBL] [Abstract][Full Text] [Related]
12. Development of a High-Performance Thin-Layer Chromatography Method for the Quantification of Alkyl Glycerolipids and Alkenyl Glycerolipids from Shark and Chimera Oils and Tissues.
Papin M; Guimaraes C; Pierre-Aue B; Fontaine D; Pardessus J; Couthon H; Fromont G; Mahéo K; Chantôme A; Vandier C; Pinault M
Mar Drugs; 2022 Apr; 20(4):. PubMed ID: 35447943
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Principe P; Sidoti C; Braquet P
Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of ether lysophospholipids in Leishmania donovani promastigotes.
Achterberg V; Gercken G
Mol Biochem Parasitol; 1987 Dec; 26(3):277-87. PubMed ID: 3431573
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
16. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
17. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of alkylglycerols in plant cell cultures: production of platelet activating factor and other biologically active ether lipids.
Mangold HK; Apte SS; Weber N
Lipids; 1991 Dec; 26(12):1086-92. PubMed ID: 1819691
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Noseda A; Berens ME; White JG; Modest EJ
Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
